Abstract
One hundred and twenty‐three specimens (83 primary and 40 metastatic) of colorectal cancers from 102 patients were subjected to the human tumor clonogenic assay (HTCA) to determine the clonogenicities of tumor specimens stratified by the degree of histological differentiation and of tumor progression. No statistically significant differences in the clonogenicity were observed among the tumors with different histological differentiation. Viable malignant cells were abundant in the primary tumor specimens with submucosal (sm) and muscular layer (pm) invasion, and decreased significantly in number per gram of wet specimen as the tumors progressed (P<0.05). Clonogenicity was also higher in “smd” and “pm” primary tumor specimens, and decreased as the tumors advanced (P<0.05). These findings suggest that, at the onset or in the relatively early phase of the tumor progression, tumors are medullary and have a large fraction of clonogenic cells, and that they then develop more stroma while losing the clonogenic cell fraction by tumor progression. HTCA appears to be still valuable for analysis of the changes in biological properties over time in large bowel tumors.
Keywords: Human tumor clonogenic assay, Colony‐forming ability, Tumor progression
Full Text
The Full Text of this article is available as a PDF (268.3 KB).
REFERENCES
- 1. ) Hamburger , A. W. and Salmon , S. E. Primary bioassay of human tumor stem cells . Science , 197 , 461 – 463 ( 1977. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Salmon , S. E. Human tumor colony assay and chemo‐sensitivity testing . Cancer Treat. Rep. , 68 , 117 – 125 ( 1984. ). [PubMed] [Google Scholar]
- 3. ) Bertelsen , C. A. , Sondak , V. K. , Mann , B. D. , Korn , E. L. and Kern , D. H. Chemosensitivity testing of human solid tumors: a review of 1582 assays with 258 clinical correlations . Cancer , 53 , 1240 – 1245 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Shoemaker , R. H. , Wolpert‐DeFilippes , M. K. , Kern , D. H. , Lieber , M. M. , Makuch , R. W. , Melnick , N. R. , Miller , W. T. , Salmon , S. E. , Simon , R. M. , Venditti , J. M. and Von Hoff , D. D. Application of human tumor colonyforming assay to new drug screening . Cancer Res. , 45 , 2145 – 2153 ( 1985. ). [PubMed] [Google Scholar]
- 5. ) Salmon , S. E. , Hamburger , A. W. , Soehnlen , B. J. , Durie , B. G. M. , Alberts , D. S. and Moon , T. E. Quantitation of differential sensitivity of human tumor stem cells to anti‐cancer drugs . N. Engl. J. Med. , 298 , 1321 – 1327 ( 1978. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Shimizu , E. , Saijo , N. , Kanzawa , F. , Hoshi , A. , Eguchi , K. , Shinkai , T. , Tominaga , K. , Sasaki , Y. , Fujita , J. , Nomori , H. , Futami , H. and Miyazawa , N. Correlation between drug sensitivity determined by clonogenic cell assay and clinical effect of chemotherapy in patients with primary lung cancer . Gann , 75 , 1030 – 1035 ( 1984. ). [PubMed] [Google Scholar]
- 7. ) Von Hoff , D. D. Human tumor cloning assays: applications in clinical oncology and new antineoplastic agent development . Cancer Metastases Rev. , 7 , 357 – 371 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Selby , P. , Buick , R. and Tannock , I. A critical appraisal of the “human tumor stem cell assay ” N. Engl. J. Med. , 308 , 129 – 134 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Weisenthal , L. M. and Lippman , M. E. Clonogenic and nonclonogenic in vitro chemosensitivity assays . Cancer Treat. Rep. , 69 , 615 – 631 ( 1985. ). [PubMed] [Google Scholar]
- 10. ) Ottestad , L. , Tveit , K. M. , Hannisdal , E. , Skrede , M. , Nesland , J. M. , Gundersen , S. and Pihl , A. Colony forming ability of human breast carcinomas: lack of prognostic significance . Br. J. Cancer , 60 , 216 – 219 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. ) Tanigawa , N. , Kern , D. H. , Hikasa , Y. and Morton , D. L. Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture . Cancer Res. , 42 , 2159 – 2164 ( 1982. ). [PubMed] [Google Scholar]
- 12. ) Tanigawa , N. , Mizuno , Y. , Hashimura , T. , Honda , K. , Satomura , K. , Hikasa , Y. , Niwa , O. , Sugahara , T. , Yoshida , O. , Kern , D. H. and Morton , D. L. Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony‐forming assay . Cancer Res. , 44 , 2309 – 2312 ( 1984. ). [PubMed] [Google Scholar]
- 13. ) Japanese Research Society for Cancer of Colon and Rectum . “ General Rules for Clinical and Pathological Studies on Cancer of Colon, Rectum and Anus ,” pp. 1 – 60 ( 1983. ). Kanehara Co., Ltd. , Tokyo ( in Japanese ). [Google Scholar]
- 14. ) Kern , D. H. , Drogemuller , C. R. , Kennedy , M. C. , Hildebrand‐Zanki , S. U. , Tanigawa , N. and Sondak , V. K. Development of a miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors . Cancer Res. , 45 , 5436 – 5441 ( 1985. ). [PubMed] [Google Scholar]
- 15. ) Jones , C. A. , Tsukamoto , T. , O'Brien , P. C. , Uhl , C. B. , Alley , M. C. and Lieber , M. M. Soft agarose culture human tumor colony forming assay for drug sensitivity assay: 3H‐thymidine incorporation assay vs. colony counting . Br. J. Cancer , 52 , 303 – 310 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. ) Salmon , S. E. , Grogan , T. M. , Miller , T. , Scheper , R. and Dalton , W. S. Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by p‐glycoprotein staining . J. Natl. Cancer Inst. , 81 , 68 – 70 ( 1989. ). [DOI] [PubMed] [Google Scholar]